covid vaccine - Search News

Order byBest matchMost fresh

Covid, FDA and vaccine

Digest more

FDA requires Covid vaccine makers to expand warning about risk of rare heart inflammation

The new labels will expand that warning to certain age groups.

· 2d · on MSN

Who can get updated COVID vaccines this fall? FDA will OK for high-risk groups, calls for new clinical trials

· 3h

Moderna Files FDA Application for the LP.8.1 Targeting COVID-19 Vaccine

The FDA plans to limit access to covid vaccines. Here’s why that’s not all bad.

Covid vaccines will soon be required to go through more rigorous trials to ensure that they really are beneficial for people who aren’t at high risk.

MIT Technology Review · 19h

· 1d

FDA panel recommends keeping COVID shots targeted to same strain as last year

Alaska Dispatch News · 18h

Opinion: The FDA’s new covid vaccine policy is clear as mud

US FDA Advisers to Weigh Composition of COVID Vaccines for 2025-2026

Public health experts say that there is no certainty on which strains are going to be dominant.

· 1d

With vaccine approval process set to change, FDA advisers leave wiggle room in annual Covid-19 shot recommendations

· 1d

FDA panel debates COVID vaccine recipe as questions swirl about fall shots

1don MSN

Changes are happening around COVID-19 vaccines: Here's what to know

The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels about heart inflammation.

13h

Growth Serum: Reinventing the world’s largest Covid vaccine supplier

In India, the most prominent symbol of the Covid response was the Serum Institute of India. The company became the world’s largest Covid vaccine supplier (Covishield), propelling it, and CEO Adar Poonawalla, to record revenues and global recognition.

The New Rational FDA COVID Vaccine Policy is Long Overdue, Says NanoViricides’ Dr. Diwan

SHELTON, CT / ACCESS Newswire / May 22, 2025 / Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE Amer.:NNVC ) (the “Company”), comments on the new COVID Vaccine policy adopted by the US FDA. The new FDA COVID Vaccine Booster Shots policy [1] is based on the findings that the groups that benefit from repeat